Grants for Public housing authorities - Food and Nutrition

This funding opportunity supports early stage researchers in pursuing innovative and high-risk scientific projects that significantly diverge from their previous work, without the need for preliminary data.

This funding opportunity supports innovative pilot research projects that explore the biological, behavioral, and social factors influencing HIV-related health issues, particularly those affecting kidney and digestive diseases.

The Lumpkin Family Foundation is currently accepting letters of inquiry for its Land, Health, Community (LHC) Grant Program. Donor Name: The Lumpkin Family Foundation State: Illinois County: Coles County (IL), Effingham County (IL) Grant Duration: Grant Duration Not Mentioned Details: Land, Health, Community (LHC) is the Foundation’s primary and largest grantmaking program and reflects the Lumpkin family’s historic connection and commitment to the community. A minimum of 50 percent of its annual grantmaking budget is spent on projects in East Central Illinois. Through Land, Health, Community we work toward a long-term vision of holistically healthy communities. The Lumpkin Family Foundation makes grants in East Central Illinois that reflect the vision: The community has a strong local food system and agricultural economy, resilient businesses, and amenities that attract new businesses and retain local talent. They are prosperous. The community is physically active, values healthy eating, and prioritizes overall wellbeing. They are mentally well and physically fit. The community has strong leadership and the capacity for collaboration. They are socially engaged. The community works to conserve, protect and preserve the natural environment. They value the natural beauty of the area. Mental Health The Lumpkin Family Foundation has now expanded the program’s focus to include efforts that contribute to mental wellness through individual and community engagement with the natural environment. Researchers have posited that “contact with nature is associated with increases in happiness, subjective well-being, positive affect, positive social interactions and a sense of meaning and purpose in life, as well as decreases in mental distress.” Specifically, the foundation aims to fund programs that: Demonstrate and promote a connection between engagement with nature and positive mental health outcomes; Create opportunities for youth and young adults to disengage from technology and engage in outdoor programs and activities designed to improve their mental wellness; Support mental health practitioners by increasing opportunities for self-care or personal renewal; Provide opportunities for those impacted by trauma (i.e., foster youth) to engage in nature-based healing activities. Focus Areas  Successful proposals will represent a synergy of as many of the following aims as possible: Promote personal health through widespread availability and consumption of healthy, affordable food; Support mental wellness through individual and community engagement with the natural environment; Grow the local agricultural economy, sustaining and creating new viable farm and farm-related businesses; Develop, promote and scale innovative green practices that add productive value to farms while protecting the land for future generations; and, Encourage community engagement and collaboration, policy development and research around agriculture and rural development. Geographic Areas of Interest  The Foundation encourages applicants from organizations across East Central Illinois. The foundation gives preference to rural organizations and those operating in Coles and the surrounding counties. For more information, visit TLFF.

This funding opportunity supports innovative researchers in the U.S. who are tackling significant challenges in diabetes, metabolic diseases, digestive disorders, and nutrition, with the goal of advancing groundbreaking scientific understanding and treatment.

This funding opportunity supports innovative educational projects that engage K-12 students and teachers in the biomedical and behavioral sciences, particularly targeting individuals from diverse and underrepresented backgrounds.

This funding opportunity supports postdoctoral researchers in biomedical and behavioral fields, providing mentorship and resources to help them develop into independent scientists.

This funding opportunity provides financial support for researchers to quickly evaluate new policies or programs aimed at influencing behaviors related to obesity, such as diet and physical activity, to help prevent or reduce obesity rates.

This funding opportunity supports high-risk, multi-center observational studies aimed at advancing research on diabetes, digestive diseases, kidney disorders, and other related health conditions, encouraging diverse institutions to collaborate and innovate.

This funding opportunity provides financial support for research sites to study Type 1 diabetic nephropathy by recruiting patients, conducting kidney biopsies, and collecting data to identify new treatment targets and improve precision medicine approaches.

This grant provides funding to U.S. institutions to foster collaboration and support early-career researchers in benign urology through training, resource sharing, and professional development opportunities.

This funding opportunity supports a central coordinating center that will enhance collaboration and provide resources for research in nonmalignant hematology, particularly aimed at fostering the development of junior investigators and innovative projects across multiple institutions.

The "Chronic Pancreatitis Clinical Research Consortium (CPCRC)- Clinical Centers (CPCRC-CCs)" grant aims to fund ongoing studies on chronic pancreatitis and related conditions, with a focus on understanding the risk factors for pancreatic cancer in patients with chronic pancreatitis and newly diagnosed diabetes, by supporting a consortium of clinical centers and a data management center.

This funding opportunity supports U.S.-based organizations in conducting research to better understand and manage heart-related side effects of cancer treatments, with a focus on improving detection, monitoring, and data sharing.

The purpose of this funding opportunity announcement (FOA) is to support efficient natural history studies alone or in conjunction with the development and validation of clinical outcome assessments (COAs) and/or biomarker studies to address the unmet needs in rare neurodegenerative diseases for children and adults. Through the support of studies with high quality and interpretable data elements, FDA expects to address critical knowledge gaps, remove major barriers to progress in the field, exert a significant and broad impact on a specific rare neurodegenerative disease or multiple rare neurodegenerative diseases with similar pathophysiology, and facilitate rare disease product development.

This funding opportunity provides financial support for new and underrepresented researchers in the health sciences to conduct projects aligned with the missions of NIAID or NIDDK.

Under the Resilient Food Systems Infrastructure Program managed by the Pennsylvania Department of Agriculture (PDA) and funded by the USDA Agricultural Marketing Service (AMS), Simplified Equipment-Only Grants are designed to support Pennsylvania's food system transformation. These grants, focusing on equipment purchases for small to mid-size producers and processors, aim to diversify, distribute, and localize food systems to enhance consumer access, producer options, and rural community markets. Grant amounts range from $10,000 to $100,000, requiring no cost sharing. Eligible equipment expenses include purchase costs, delivery, and installation if included in the official bid. Applications are accepted electronically, with project completion required by June 30, 2026.

The U.S. Food and Drug Administration (FDA) seeks applications to develop, implement, and evaluate a human abuse potential (HAP) study of botanical Kratom. FDA has previously warned consumers about the use of Kratom (Mitragyna speciosa), a plant indigenous to Southeast Asia. Kratom alkaloids have demonstrated both affinity and activity at receptor sites known to be associated with abuse, such as mu opioid receptors. Although Kratom use is prevalent, to date, clinical evaluations of its abuse potential have been limited. The proposed HAP study should be performed in accordance with the guidance for industry, "Assessment of Abuse Potential of Drugs," including (but not limited to) the selection of an appropriate comparator(s) and outcome measures, statistical analyses etc. Interested parties, will also complete the submission of an Investigational New Drug (IND) application and obtain Institutional Review Board (IRB) clearance.

This grant provides funding for research aimed at understanding the factors that contribute to health disparities in HIV and aging among racial and ethnic minorities, low-income populations, and other underserved groups, focusing on how multiple health conditions affect their overall well-being and quality of life.

This funding opportunity supports high-risk, multi-center clinical trials aimed at addressing significant health issues related to diabetes, digestive diseases, and kidney disorders, encouraging diverse institutions to apply for impactful research that can transform clinical practices.

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit research designed to capacitate, transform, and scale the delivery of HIV testing, prevention, and care services through pharmacists and pharmacies in US and/or global settings. This includes theadvancement of training curricula to enable pharmacy students, pharmacists, pharmacies, and pharmacy systems to deliver the spectrum of needed HIV services with ease, equity, and effectiveness. This NOFO uses the R21 grant mechanism, while RFA-MH-25-185 uses the R01 mechanism. Projects that lack preliminary data or that propose to pilot a novel intervention may be most appropriate for the R21 mechanism. Applications with preliminary data and those proposing large-scale clinical trials or longitudinal analyses should consider using the R01 mechanism.